COX-2 expression and effects of COX-2 inhibition in colorectal carcinomas and their liver metastases

Nonsteroidal anti-inflammatory drugs are known to reduce the risk and mortality from colorectal carcinoma by inhibiting cyclo-oxygenases (COX). COX-2 expression was investigated immunohistologically in 57 patients with colorectal carcinomas and in the corresponding liver metastases using tissue micr...

Full description

Saved in:
Bibliographic Details
Main Authors: Kasper, Hans-Udo (Author) , Konze, Elisabeth (Author) , Dienes, Hans Peter (Author) , Stippel, Dirk Ludger (Author) , Schirmacher, Peter (Author) , Kern, Michael A. (Author)
Format: Article (Journal)
Language:English
Published: July 22, 2010
In: Anticancer research
Year: 2010, Volume: 30, Issue: 6, Pages: 2017-2023
ISSN:1791-7530
Online Access:Verlag, kostenfrei, Volltext: https://ar.iiarjournals.org/content/30/6/2017
Get full text
Author Notes:Hans-Udo Kasper, Elisabeth Konze, Hans Peter Dienes, Dirk Ludger Stippel, Peter Schirmacher and Michael Kern
Description
Summary:Nonsteroidal anti-inflammatory drugs are known to reduce the risk and mortality from colorectal carcinoma by inhibiting cyclo-oxygenases (COX). COX-2 expression was investigated immunohistologically in 57 patients with colorectal carcinomas and in the corresponding liver metastases using tissue microarray analysis. Ex vivo COX-2 inhibition with assessment of apoptosis was performed using precision-cut tissue slices of three human liver metastases. Following stimulation with different concentrations of the selective COX-2 inhibitor meloxicam, apoptosis was assessed immunohistochemically after 6 h and 12 h. All primary carcinomas and 56 out of the 57 liver metastases showed various degrees of cytoplasmatic COX-2 expression being with a reduction and in the liver metastases. There was a time- and concentration-dependent change in the number of apoptotic cells in tissue slices, however, this was without statistical significance. COX-2 is constantly involved in the carcinogenesis and metastatic process of colorectal cancer. The antineoplastic effect of COX-2 inhibition may be based on different pathways, including changes in sensitivity to apoptosis.
Item Description:Gesehen am 07.03.2023
Physical Description:Online Resource
ISSN:1791-7530